2023 Corporate Advisory Council

APSF is pleased to recognize the following companies for their exceptional level of support of APSF


2023 Corporate Advisory Council

Platinum Level ($50,000)

Fresenius KabiFresenius Kabi (fresenius-kabi.us) is a global health care company that specializes in lifesaving medicines and technologies that are used to help care for critically and chronically ill patients, offering injectable medicine portfolios for anesthesia providers and a growing number of ready-to-administer products.

GE HealthcareGE Healthcare (gehealthcare.com) is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, that enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

Gold Level ($30,000)

BDBD Blink Device Company
Blink Device Company
Eagle Pharmaceuticals
Eagle Pharmaceuticals
Edwards Lifesciences
Edwards Lifesciences

ICU Medical
MasimoMasimo

Medtronic
MerckMerck
Nihon Kohden America
Nihon Kohden America
Philips Healthcare
Philips Healthcare

Preferred Physicians Medical Risk Retention Group
Vyaire Medical
Vyaire Medical

Silver Level ($10,000)

Dräger ($15,000)

Senzime

 

Special recognition and thank you to Medtronic for their support and funding of the APSF/Medtronic Patient Safety Research Grant ($150,000); and Merck for their educational grant.

 

For more information about how your organization can support the APSF mission and participate in the 2023 Corporate Advisory Council, go to: apsf.org or contact Sara Moser at: [email protected].